Related Experiment Videos
Left ventricular malposition of a transvenous cardioverter defibrillator lead: a 3-year follow-up
Pacing and Clinical Electrophysiology : PACE
|June 20, 1998
Insights
A transvenous implantable cardioverter defibrillator lead was successfully placed in the left ventricle via an atrial septal defect. This case demonstrates a safe and effective management strategy with a 3-year uneventful follow-up.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Transvenous lead implantation is a standard procedure for implantable cardioverter defibrillators (ICDs).
- Atrial septal defects (ASDs) can present unique challenges for lead placement.
- Left ventricular lead malposition is a rare complication.
Observation:
- A case report detailing a patient with an ASD requiring ICD implantation.
- The transvenous ICD lead was intentionally directed through the ASD into the left ventricle.
- The patient was managed with continuous warfarin anticoagulation.
Findings:
- Successful left ventricular lead placement via an ASD was achieved.
- The patient remained on warfarin anticoagulation throughout the follow-up period.
- No adverse events or complications were observed during the 3-year follow-up.
Implications:
- This case highlights a potential alternative approach for ICD lead placement in patients with ASDs.
- Continuous anticoagulation with warfarin may be a viable strategy for managing such cases.
- Further research is warranted to evaluate the long-term safety and efficacy of this technique.
Abstract:
A case of left ventricular malposition of a transvenous implantable cardioverter defibrillator lead through an atrial septal defect is presented. The patient has been continually anticoagulated with warfarin. A 3-year follow-up has thus far been uneventful.